These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28708568)
1. Reference values of fecal calgranulin C (S100A12) in school aged children and adolescents. Heida A; Kobold ACM; Wagenmakers L; van de Belt K; van Rheenen PF Clin Chem Lab Med; 2017 Nov; 56(1):126-131. PubMed ID: 28708568 [TBL] [Abstract][Full Text] [Related]
2. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Sidler MA; Leach ST; Day AS Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298 [TBL] [Abstract][Full Text] [Related]
3. Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study. Heida A; Van de Vijver E; Muller Kobold A; van Rheenen P BMJ Open; 2017 May; 7(5):e015636. PubMed ID: 28554936 [TBL] [Abstract][Full Text] [Related]
4. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests. Heida A; Van de Vijver E; van Ravenzwaaij D; Van Biervliet S; Hummel TZ; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; van Rheenen PF; Arch Dis Child; 2018 Jun; 103(6):565-571. PubMed ID: 29514815 [TBL] [Abstract][Full Text] [Related]
5. Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. de Jong NS; Leach ST; Day AS Inflamm Bowel Dis; 2006 Jul; 12(7):566-72. PubMed ID: 16804393 [TBL] [Abstract][Full Text] [Related]
6. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12. Whitehead SJ; Ford C; Gama RM; Ali A; McKaig B; Waldron JL; Steed H; Brookes MJ J Clin Pathol; 2017 Dec; 70(12):1049-1056. PubMed ID: 28735301 [TBL] [Abstract][Full Text] [Related]
7. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327 [TBL] [Abstract][Full Text] [Related]
8. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study. Cenni S; Casertano M; Trani M; Pacella D; Martinelli M; Staiano A; Miele E; Strisciuglio C Eur J Pediatr; 2023 Mar; 182(3):1299-1308. PubMed ID: 36637538 [TBL] [Abstract][Full Text] [Related]
9. Fecal S100A12 concentrations in cats with chronic enteropathies. Zornow KA; Slovak JE; Lidbury JA; Suchodolski JS; Steiner JM J Feline Med Surg; 2023 Mar; 25(3):1098612X231164273. PubMed ID: 36995216 [TBL] [Abstract][Full Text] [Related]
10. Performance of fecal S100A12 as a novel non-invasive diagnostic biomarker for pediatric inflammatory bowel disease: a systematic review and meta-analysis. Witarto BS; Visuddho V; Witarto AP; Sampurna MTA; Irzaldy A J Pediatr (Rio J); 2023; 99(5):432-442. PubMed ID: 37094752 [TBL] [Abstract][Full Text] [Related]
11. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease. Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653 [TBL] [Abstract][Full Text] [Related]
12. Test Strategies to Predict Inflammatory Bowel Disease Among Children With Nonbloody Diarrhea. Van de Vijver E; Heida A; Ioannou S; Van Biervliet S; Hummel T; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; Verkade HJ; van Rheenen PF; Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32694147 [TBL] [Abstract][Full Text] [Related]
13. Fecal S100A12 concentration predicts a lack of response to treatment in dogs affected with chronic enteropathy. Heilmann RM; Volkmann M; Otoni CC; Grützner N; Kohn B; Jergens AE; Steiner JM Vet J; 2016 Sep; 215():96-100. PubMed ID: 27017054 [TBL] [Abstract][Full Text] [Related]
14. Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12. Däbritz J; Langhorst J; Lügering A; Heidemann J; Mohr M; Wittkowski H; Krummenerl T; Foell D Inflamm Bowel Dis; 2013 May; 19(6):1130-8. PubMed ID: 23377171 [TBL] [Abstract][Full Text] [Related]
15. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869 [TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy. Sipponen T; Haapamäki J; Savilahti E; Alfthan H; Hämäläinen E; Rautiainen H; Koskenpato J; Nuutinen H; Färkkilä M Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease detection and monitoring by measuring biomarkers in non-invasively collected colorectal mucus. Loktionov A; Chhaya V; Bandaletova T; Poullis A J Gastroenterol Hepatol; 2017 May; 32(5):992-1002. PubMed ID: 27787913 [TBL] [Abstract][Full Text] [Related]
18. Analytical validation of an enzyme-linked immunosorbent assay for the quantification of S100A12 in the serum and feces of cats. Bridges CS; Grützner N; Suchodolski JS; Steiner JM; Heilmann RM Vet Clin Pathol; 2019 Dec; 48(4):754-761. PubMed ID: 31820477 [TBL] [Abstract][Full Text] [Related]
19. Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy. Heilmann RM; Nestler J; Schwarz J; Grützner N; Ambrus A; Seeger J; Suchodolski JS; Steiner JM; Gurtner C Vet Immunol Immunopathol; 2019 May; 211():64-74. PubMed ID: 31084897 [TBL] [Abstract][Full Text] [Related]
20. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]